From: Ethical considerations of the vaccine development process and vaccination: a scoping review
No. | Author | Subject | Study type | Scope | Discussed Ethical Issues | |||
---|---|---|---|---|---|---|---|---|
Autonomy | Non-maleficence | Beneficence | Justice | |||||
1 | Calina, D. 2021 [4] | Describing the ethical considerations of trial & Intentionally infecting healthy volunteers | Review | Vaccine production | * | * | ||
2 | Dal-Ré, R. 2021 [16] | Challenges of equitable distribution and clinical trials of vaccines in low-income countries | Review | Vaccine production | * | * | ||
3 | Daverio, M. 2021 [10] | An overview of ethical and regulatory issues & Vaccine research and the consequences of informed consent | Review | Vaccine production | * | * | * | |
4 | Greco, D. B. 2021 [12] | Ethical limitations on using placebo and access to Covid-19 vaccines | Review | Vaccine production & distribution | * | * | * | |
5 | John, T. J. [5] | Covid-19 vaccine trials and ethics | Review | Vaccine production & distribution | * | * | * | |
6 | Kashte, S. 2021 [17] | Challenges and implications of the development of vaccines at present and in the future | Review | Vaccine production | * | * | ||
7 | Monrad, J. T. 2020 [18] | Ethical considerations for vaccine trials | Review | Vaccine production | * | * | ||
8 | Vashishtha, V. M. 2021 [2] | Emergency use authorization of Covid-19 vaccines | Review | Vaccine production | * | * | * | * |
9 | Wibawa, T. 2021 [19] | Ethical considerations of research and development of Covid-19 vaccines | Review | Vaccine production | * | * | * | |
10 | Brusa, M. 2021 [20] | Vaccine policymaking for children in emergencies | Review | Vaccine production & distribution | * | * | * | |
11 | Dembinski, L. 2021 [21] | Vaccination in children and adolescents | Review | Vaccine distribution | * | * | * | |
12 | Hamidian Jahromi, A. 2021 [22] | Ethical considerations regarding mandatory vaccination for healthcare providers | Review | Vaccine distribution | * | * | * | |
13 | Hughes, K. 2021 [23] | Ethical considerations and fair prioritization of vaccines in HCWs | Review | Vaccine distribution | * | |||
14 | Kates, O. S. 2021 [24] | Ethical considerations of vaccination for transplant center staff and patients | Review | Vaccine distribution | * | * | * | * |
15 | Bolcato, M. 2021 [13] | Fair distribution of anti-COVID-19 vaccines resources | Review | Vaccine distribution | * | |||
16 | Carson, S. L. 2021 [25] | Vaccine Challenges of multiethnic societies | Qualitative | Vaccine distribution | * | * | * | * |
17 | Adejumo, O. A. 2021 [26] | Global health coverage approach and justice in the vaccine distribution plan | Review | Vaccine distribution | * | |||
18 | Binagwaho, A. 2021 [27] | Management of ethical considerations in vaccination | Review | Vaccine production & Distribution | * | * | * | |
19 | Martin-Fumadó, C. 2021 [28] | Ethical considerations of vaccination in health care providers | Review | Vaccine distribution | * | * | ||
20 | Reis-Dennis, S. 2021 [29] | Ethical considerations of vaccines in health care providers | Review | Vaccine distribution | * | |||
21 | Savulescu, J. 2021 [30] | Ethical considerations of compulsory vaccination in children | Review | Vaccine distribution | * | * | * | |
22 | Thorsteinsdottir, B. 2021 [31] | Ethical analysis of prioritizing HCWs for access to the vaccine | Review | Vaccine distribution | * | |||
23 | Williamson, L. 2021 [32] | Ethical considerations in the vaccination of children | Review | Vaccine distribution | * | * | ||
24 | Brown, R. C. H. 2021 [33] | Challenges and ethical considerations of immunity passports | Review | Vaccine distribution | * | * | ||
25 | Giubilini, A. 2021 [9] | Ethical considerations of vaccination | Review | Vaccine distribution | * | * | * | * |
26 | McClung, N. 2021 [34] | Describing the four ethical principles of the Advisory Committee on Immunization Practices (ACIP) | Review | Vaccine distribution | * | * | ||
27 | Kumar, V. 2021 [6] | Ethical considerations of vaccine trials | Review | Vaccine production & distribution | * | * | * | * |
28 | Mirocha, L. 2021 [35] | Ethical considerations of vaccine distribution | Review | Vaccine distribution | * | |||
29 | Sharma, P. 2021 [8] | Ethical considerations of vaccination | Review | Vaccine distribution | * | * | * | * |
30 | Sharun, K. 2021 [36] | Ethical considerations of immunity passports | Review | Vaccine distribution | * | * | ||
31 | Voo, T. C. 2021 [37] | Ethical considerations of immunity passports | Review | Vaccine distribution | * | * | * | |
32 | Wang, D. W. L. 2021 [3] | Ethical considerations of mandatory vaccination | Review | Vaccine distribution | * | * | * | |
33 | Woodhead, C. 2021 [38] | Ethical considerations of racial and ethnic group vaccination | Qualitative | Vaccine distribution | * | * | * | * |
34 | Zhu, X. G. 2021 [39] | Impact of racism and inequality on equitable vaccine distribution | Review | Vaccine distribution | * | * | * | * |
35 | Emanuel, E. J. 2020 [14] | An ethical framework for global vaccine distribution | Review | Vaccine distribution | * | * | * | |
36 | Gupta, R. 2021 [1] | Ethical issues of vaccine distribution | Review | Vaccine distribution | * | * | ||
37 | Liu, Y. 2020 [40] | Providing an ethical framework for fair global vaccine distribution | Review | Vaccine distribution | * | |||
38 | McMahon, A. 2021 [41] | Fair global access to vaccines, medicines, and diagnostic equipment and the role of patents | Review | Vaccine production & distribution | * | |||
39 | Rhodes, R. 2021 [42] | Ethical considerations of justice in vaccine prioritization | Review | Vaccine distribution | * | |||
40 | Hughes, J. A. 2020 [43] | Challenges and implications of new vaccine technologies | Conference article | Vaccine distribution | * | * | ||
41 | WHO, 2021 [44] | Ethical considerations of Covid-19 and vaccination | Report | Vaccine distribution | * | |||
42 | WHO. 2021 [45] | Review the ethical considerations and dilemmas of decision-making to respond to the epidemic | Report | Vaccine distribution | * | |||
43 | WHO, 2020 [46] | Ethical considerations of trials and emergency use of vaccines | Report | Vaccine production | * | * |